Caricamento quotazioni...
Previsioni
| Acquista |
0 |
| Mantieni |
0 |
| Vendi |
1 |
Discussioni nella community
Non ci sono ancora discussioni su questo asset.
Avvia discussioneNotizie Vai al feed delle notizie
Corbion cuts adjusted EBITDA margin guidance and shares fall sharply
Corbion lowered its forecast for the adjusted EBITDA margin for 2026 to above 16% (previously around 17%), sending the share price down about 3.8%. Management cited macroeconomic uncertainty and unexpected cost inflation from the Middle East conflict (commodity prices, freight rates, energy costs) as reasons. The revenue growth target (organic 3–6%) and free cash flow (€85–90m) remained unchanged, but weak cash generation in Q2 and a working-capital outflow amplified the market reaction. Analysts viewed the margin revision as negative and the share move as company-specific rather than market-wide. » Altro su de.investing.com
Corbion Q1 2026: revenue stable, margins under pressure and stock falls
Corbion reported Q1 2026 revenue of €294 million and adjusted EBITDA of €37.8 million (margin 12.9%). The stock fell 6.08% to €19.24 after the figures. The Functional Ingredients & Solutions segment is under margin pressure, while Health & Nutrition benefits from robust demand. Free cash flow was seasonally at -€15.7 million; management confirms full-year FCF of €85–90 million and expects near-term improvements from cost reductions. » Altro su de.investing.com
Corbion: undiluted earnings per share in 2025 rise 63% to €1.29 thanks to margin expansion
Corbion reports undiluted earnings per share of €1.29 for 2025 (+63.3%), driven by a significant expansion in margins; net revenue was €1,267.4m, adjusted EBITDA €204.3m (margin 16.1%, +250 basis points). In Q4, volume and mix growth and organic adjusted EBITDA accelerated, and free cash flow for the year amounted to €90.8m. The board proposes a total distribution of €1.00 per share (€0.64 regular, €0.36 special dividend); net debt fell to 1.5x EBITDA. For 2026 Corbion expects organic revenue growth of 3–6%, an adjusted EBITDA margin of around 17% and free cash flow of €85–90m; in the short term Q1 2026 is likely to be below the strong prior year, and negative currency effects weighed on the market reaction. » Altro su de.investing.com
Corbion presents "BRIGHT 2030" strategy and drags down stock
Corbion presented the "BRIGHT 2030" strategy with financial targets for 2026–2028: organic revenue growth of 3–6% per year, an EBITDA margin of about 18% by 2028, cumulative free cash flow of €270 million, and a rise in ROCE to around 13%. Management also aims for double‑digit annual earnings‑per‑share growth. Investors reacted negatively; the stock posted continuous losses after the announcement. » Altro su de.investing.com
Dividendi storici Dividendi
Tutte le metriche sui dividendi Tutte le metricheDati finanziari dell'azienda
| (EUR) | giugno 2026 | YoY |
|---|---|---|
| Ricavi | 631,1 Mln | - |
| Utile lordo | 154,4 Mln | - |
| Utile netto | 29,8 Mln | - |
| EBITDA | 88,8 Mln | - |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 1,53 Mld € |
Numero di azioni | 57,63 Mln |
Massimo/minimo a 52 settimane | 27,76 € - 17,26 € |
Rendimento da dividendo | 3,77% |
Dividendi TTM | 1,00 € |
Beta | 0,87 |
Rapporto P/E | 24,59 |
Rapporto PEG | -2,90 |
Rapporto P/B | 2,03 |
Rapporto P/S | 1,22 |
Profilo aziendale
Corbion N.V. produce acido lattico e derivati dell'acido lattico, emulsionanti, miscele di enzimi funzionali, minerali, vitamine e ingredienti a base di alghe in tutto il mondo. L'azienda offre soluzioni di ingredienti realizzate con risorse rinnovabili per i mercati alimentare, della cura della casa e della persona, farmaceutico, della nutrizione animale, dei dispositivi medici e delle bioplastiche. Commercializza i propri prodotti attraverso una rete di uffici vendita e distributori. L'azienda era precedentemente nota come CSM N.V. e ha cambiato denominazione in Corbion N.V. nell'ottobre 2013. Corbion N.V. è stata fondata nel 1919 e ha sede ad Amsterdam, nei Paesi Bassi.
| Nome | Corbion |
| CEO | Olivier Rigaud |
| Sede centrale | Amsterdam,
nh Paesi Bassi |
| Sito web | |
| Quotazione in borsa | 29/03/1995 |
| Dipendenti | 2363 |
Simboli di borsa
| Borsa | Simbolo |
|---|---|
Euronext | CRBN.AS |
Pnk | CSNVF |
Amsterdam | CRBN.AS |
Frankfurt | CSUA.F |
Düsseldorf | CSUA.DU |
London | 0QHL.L |
SIX | CSUA.SW |
München | CSUA.MU |